Related Experiment Video
Updated: May 17, 2026

The bm12 Inducible Model of Systemic Lupus Erythematosus (SLE) in C57BL/6 Mice
Published on: November 1, 2015
Comparative safety of therapies in systemic lupus erythematosus
1Division of Rheumatology and Allergy-Clinical Immunology, North Shore-Long Island Jewish Health System, Lake Success, NY 11042, USA. jmosak@nshs.edu
Abstract:
Systemic lupus erythematosus (SLE) is the prototypic autoimmune disease with diverse clinical manifestations, affecting virtually all organ systems. A wide variety of medications are used for treatment, depending on organ involvement and severity. This article summarizes the adverse effects associated with different drugs currently used to treat SLE.
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Therapeutic Drug Monitoring: Overview and Classification
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Therapeutic Drug Monitoring: Affecting Factors
Drug Therapy
Antianxiety Medications
Nephrotic Syndrome II : Assessment and Medical Management